Cambridge, UK, 24th May 2018 / Sciad Newswire / Check4Cancer is delighted to announce the appointment of Louise Mills as Director of Clinical Services. Louise will operate across the wide range of Check4Cancer’s clinical services, helping to maintain standards of clinical excellence and patient-focused care. She brings to the team a wealth of experience in senior nursing and clinical management roles, having previously worked for BUPA, HCA International Ltd and Genesis Care.
Professor Gordon Wishart, founder and Chief Medical Officer of Check4Cancer, said, “Louise’s appointment will strengthen our clinical leadership team, and improve our delivery of high quality early cancer detection services for the private, insured and corporate sectors. Securing a candidate of such high calibre to this senior clinical role illustrates our commitment to deliver clinical excellence as we improve cancer diagnostics in the private sector.”
Louise commented, “Check4Cancer is taking significant steps towards meeting the unmet need for private early cancer detection in the UK. Its ambition to improve clinical governance by providing protocol-driven diagnostic protocols for breast and skin cancer that can be audited greatly attracted me to this role, and I look forward to joining such an innovative and ambitious team.”
For further information, contact:
Professor Gordon Wishart
T: 0800 085 6663
Sciad Communications, Media Relations
Emma Pickup / Juliette Craggs
T: +44 (0)20 7470 8801
Notes to Editors
Check4Cancer is the reliable and trusted provider of early cancer detection and genetic services in the UK. The Company offers rapid access to personalised screening and diagnostic services for anyone anxious about a possible cancer diagnosis, as well as genetic testing and counselling for patients at increased risk of hereditary cancer. Check4Cancer covers bowel, breast, cervical, lung, prostate and skin cancer for the private, insured and corporate markets.
Check4Cancer enables people to take ownership of their health, and that of their family, by providing cancer services that are innovative, validated and effective. The company’s team of cancer specialists has extensive clinical expertise, enabling Check4Cancer to provide award-winning services trusted by leading UK insurance providers and corporate sector clients.
Founded in 2007, Check4Cancer’s nationwide, evidence-based services are supported by audit data and cover 87% of all new cancer incidence in the UK every year. Services can be accessed at over 80 clinics across the UK.
Check4Cancer partners with companies in the UK, USA & Europe, facilitating the offering of cancer screening and awareness as an employee benefit. Existing corporate clients include BBC, Novartis, Sky, VW, Deloitte, HP, Lendlease, Unicredit, Nissan, Volvo and Zurich.
Check4Cancer helps combat one of the fastest growing areas of medical need, as cancer is predicted to impact 1 in 2 people by 20201. Early detection gives patients a better chance of surviving cancer2, and Check4Cancer is the first step.